甲状腺素对甲状腺功能减退症大鼠海马syntaxin-1蛋白表达的影响

目的 研究成年期甲状腺功能减退症(简称甲减)大鼠海马突触前膜蛋白syntaxin-1的表达及不同剂量甲状腺素替代治疗的作用,探讨甲减脑损伤可能的分子机制.方法 健康3月龄成年SD雄性大鼠44只,体质量250 ～ 300 g,按体质量随机分为4组:甲减组、常规治疗组、大剂量治疗组和对照组,每组11只.甲减组、常规治疗组和大剂量治疗组每日腹腔注射丙基硫氧嘧啶(PTU) 10 mg/kg;4周后,甲减组继续给予PTU腹腔注射2周,常规治疗组和大剂量治疗组每日分别给予50、200μg/kg左旋甲状腺素腹腔注射2周;对照组每日腹腔注射等量生理盐水.造模结束后,采用放射免疫法检测4组大鼠血清T3、T4水平;采用免疫组化法检测4组大鼠海马syntaxin-1蛋白的表达.结果 与对照组[(0.65±0.05)、(55.20±3.56)nmol/L]比较,甲减组血清T3、T4[(0.34±0.04)、(43.01±2.95)nmol/L]明显降低(P均＜0.05),大剂量治疗组血清T3、T4[(1.11±0.10)、(96.68±6.42)nmol/L]显著升高(P均＜0.05);常规治疗组血清T3、T4[(0.63±0.05)、(55.04±3.77)nmol/L]与对照组比较,差异无统计学意义(P均＞0.05).甲减组大鼠海马CA1、CA3区起始层、放射层、腔隙层和齿状回(DG)分子层、多形层syntaxin-1蛋白表达水平(0.059±0.016、0.064±0.014、0.068±0.016,0.069±0.017、0.072±0.016、0.070±0.011,0.051±0.012、0.072±0.017)显著高于对照组(0.037±0.008、0.045±0.010、0.042±0.009,0.040±0.010、0.053±0.009、0.042±0.009,0.032±0.007、0.047±0.010,P均＜0.05);常规治疗组和大剂量治疗组各层syntaxin-1蛋白表达水平(0.041±0.011、0.046±0.017、0.044±0.014,0.037±0.008、0.051±0.010、0.043±0.010,0.033±0.011、0.045±0.014和0.040±0.010、0.045±0.011、0.043±0.010,0.033±0.009、0.050±0.010、0.041±0.009,0.032±0.009、0.046±0.009)较甲减组降低(P均＜ 0.05),与对照组比较,差异无统计学意义(P均＞0.05).结论 成年期甲减大鼠海马内syntaxin-1蛋白表达增加,常规剂量甲状腺素替代治疗能使其恢复至正常水平.     

Effect of thyroid hormone level on the expression of synaptotagmin Ⅰ in adult rat hippocampus

Objective To observe the effect of different thyroid hormone level on the expression of synaptotagmin Ⅰ(Syt Ⅰ) in adult rat hippocampus. Methods All 28 adult male SD rats were assigned randomly into hypothyroid, hyperthyroid and control group, hypothyroid group was established by daily intraperitoneal injections with propylthiou raci(PTU, 10.0 mg/kg body weight) for 6 weeks and hyperthyroid group with L-Thyroxine (L-T4, 0.5 mg/kg body weight) for 3 weeks. Radioimmunity method was used to assay the levels of serum T3 and T4, immunohistochemical S-P technology to assay the levels of Syt Ⅰ protein in hippoeampus CA1, CA3 and dentate gyrus (DG). The layers analyzed in the different subfields include the polymorphic cell layer(the stratum oriens, SO), pyramidal cell layer(PCL), stratum radiatum (SR), lacunosum-molecular layer (SLM) in CA1 and CA3, granular cell layer(GL) and molecular layer(ML) in DG. Results The levels of serum T3 and T4[(0.34±0.12), (41.03± 11.37)nmol/L]in the hypothyroid rats were significantly lower than those in the control group[(0.65±0.15), (55.20±10.68)nmol/L, P < 0.01 or < 0.05], and the positive granule of Syt Ⅰ was significantly lower in PCL and SR of CA1 and CA3, GL of DG. The average optical value responsible for Syt Ⅰ immunoreactivity was obviously reduced in SO(0.048±0.007), PCL(0.299±0.035), SR(0.042±0.007), SLM(0.038±0.006) of CA1, PCL(0.085± 0.019), SR(0.040±0.011), SLM (0.038±0.006) of CA3, GL (0.076±0.019) of DG than normal controls (0.068± 0.014, 0.376±0.053, 0.053±0.008,0.056±0.009,0.118±0.026,0.052±0.010,0.053±0.009,0.099±0.015; P< 0.01 or < 0.05). Serum T3 and T4 levels [(1.43±0.30), (157.18±19.95)nmol/L]of hyperthyroid rats were significantly higher than those of control group(P < 0.01). The value was reduced in PCL(0.322±0.050), SR(0.039±0.006), SLM (0.042±0.006) of CA1, PCL(0.098±0.034), SR(0.046±0.013), SLM(0.046±0.010) of CA3 and GL(0.085± 0.024), ML (0.042±0.009) of DG (P < 0.05 or < 0.01). Conclusion Adult-onset of hypothyroidism and hyperthyroidism can reversibly decrease the expression of Syt Ⅰ in CA1, CA3 and DG regions of hippocampus.     

Effect of thyroid hormone level on the expression of synaptotagmin Ⅰ in adult rat hippocampus

Objective To observe the effect of different thyroid hormone level on the expression of synaptotagmin Ⅰ(Syt Ⅰ) in adult rat hippocampus. Methods All 28 adult male SD rats were assigned randomly into hypothyroid, hyperthyroid and control group, hypothyroid group was established by daily intraperitoneal injections with propylthiou raci(PTU, 10.0 mg/kg body weight) for 6 weeks and hyperthyroid group with L-Thyroxine (L-T4, 0.5 mg/kg body weight) for 3 weeks. Radioimmunity method was used to assay the levels of serum T3 and T4, immunohistochemical S-P technology to assay the levels of Syt Ⅰ protein in hippoeampus CA1, CA3 and dentate gyrus (DG). The layers analyzed in the different subfields include the polymorphic cell layer(the stratum oriens, SO), pyramidal cell layer(PCL), stratum radiatum (SR), lacunosum-molecular layer (SLM) in CA1 and CA3, granular cell layer(GL) and molecular layer(ML) in DG. Results The levels of serum T3 and T4[(0.34±0.12), (41.03± 11.37)nmol/L]in the hypothyroid rats were significantly lower than those in the control group[(0.65±0.15), (55.20±10.68)nmol/L, P < 0.01 or < 0.05], and the positive granule of Syt Ⅰ was significantly lower in PCL and SR of CA1 and CA3, GL of DG. The average optical value responsible for Syt Ⅰ immunoreactivity was obviously reduced in SO(0.048±0.007), PCL(0.299±0.035), SR(0.042±0.007), SLM(0.038±0.006) of CA1, PCL(0.085± 0.019), SR(0.040±0.011), SLM (0.038±0.006) of CA3, GL (0.076±0.019) of DG than normal controls (0.068± 0.014, 0.376±0.053, 0.053±0.008,0.056±0.009,0.118±0.026,0.052±0.010,0.053±0.009,0.099±0.015; P< 0.01 or < 0.05). Serum T3 and T4 levels [(1.43±0.30), (157.18±19.95)nmol/L]of hyperthyroid rats were significantly higher than those of control group(P < 0.01). The value was reduced in PCL(0.322±0.050), SR(0.039±0.006), SLM (0.042±0.006) of CA1, PCL(0.098±0.034), SR(0.046±0.013), SLM(0.046±0.010) of CA3 and GL(0.085± 0.024), ML (0.042±0.009) of DG (P < 0.05 or < 0.01). Conclusion Adult-onset of hypothyroidism and hyperthyroidism can reversibly decrease the expression of Syt Ⅰ in CA1, CA3 and DG regions of hippocampus.     

Effect of thyroid hormone level on the expression of synaptotagmin Ⅰ in adult rat hippocampus

Objective To observe the effect of different thyroid hormone level on the expression of synaptotagmin Ⅰ(Syt Ⅰ) in adult rat hippocampus. Methods All 28 adult male SD rats were assigned randomly into hypothyroid, hyperthyroid and control group, hypothyroid group was established by daily intraperitoneal injections with propylthiou raci(PTU, 10.0 mg/kg body weight) for 6 weeks and hyperthyroid group with L-Thyroxine (L-T4, 0.5 mg/kg body weight) for 3 weeks. Radioimmunity method was used to assay the levels of serum T3 and T4, immunohistochemical S-P technology to assay the levels of Syt Ⅰ protein in hippoeampus CA1, CA3 and dentate gyrus (DG). The layers analyzed in the different subfields include the polymorphic cell layer(the stratum oriens, SO), pyramidal cell layer(PCL), stratum radiatum (SR), lacunosum-molecular layer (SLM) in CA1 and CA3, granular cell layer(GL) and molecular layer(ML) in DG. Results The levels of serum T3 and T4[(0.34±0.12), (41.03± 11.37)nmol/L]in the hypothyroid rats were significantly lower than those in the control group[(0.65±0.15), (55.20±10.68)nmol/L, P < 0.01 or < 0.05], and the positive granule of Syt Ⅰ was significantly lower in PCL and SR of CA1 and CA3, GL of DG. The average optical value responsible for Syt Ⅰ immunoreactivity was obviously reduced in SO(0.048±0.007), PCL(0.299±0.035), SR(0.042±0.007), SLM(0.038±0.006) of CA1, PCL(0.085± 0.019), SR(0.040±0.011), SLM (0.038±0.006) of CA3, GL (0.076±0.019) of DG than normal controls (0.068± 0.014, 0.376±0.053, 0.053±0.008,0.056±0.009,0.118±0.026,0.052±0.010,0.053±0.009,0.099±0.015; P< 0.01 or < 0.05). Serum T3 and T4 levels [(1.43±0.30), (157.18±19.95)nmol/L]of hyperthyroid rats were significantly higher than those of control group(P < 0.01). The value was reduced in PCL(0.322±0.050), SR(0.039±0.006), SLM (0.042±0.006) of CA1, PCL(0.098±0.034), SR(0.046±0.013), SLM(0.046±0.010) of CA3 and GL(0.085± 0.024), ML (0.042±0.009) of DG (P < 0.05 or < 0.01). Conclusion Adult-onset of hypothyroidism and hyperthyroidism can reversibly decrease the expression of Syt Ⅰ in CA1, CA3 and DG regions of hippocampus.     

Effect of thyroid hormone level on the expression of synaptotagmin Ⅰ in adult rat hippocampus

Objective To observe the effect of different thyroid hormone level on the expression of synaptotagmin Ⅰ(Syt Ⅰ) in adult rat hippocampus. Methods All 28 adult male SD rats were assigned randomly into hypothyroid, hyperthyroid and control group, hypothyroid group was established by daily intraperitoneal injections with propylthiou raci(PTU, 10.0 mg/kg body weight) for 6 weeks and hyperthyroid group with L-Thyroxine (L-T4, 0.5 mg/kg body weight) for 3 weeks. Radioimmunity method was used to assay the levels of serum T3 and T4, immunohistochemical S-P technology to assay the levels of Syt Ⅰ protein in hippoeampus CA1, CA3 and dentate gyrus (DG). The layers analyzed in the different subfields include the polymorphic cell layer(the stratum oriens, SO), pyramidal cell layer(PCL), stratum radiatum (SR), lacunosum-molecular layer (SLM) in CA1 and CA3, granular cell layer(GL) and molecular layer(ML) in DG. Results The levels of serum T3 and T4[(0.34±0.12), (41.03± 11.37)nmol/L]in the hypothyroid rats were significantly lower than those in the control group[(0.65±0.15), (55.20±10.68)nmol/L, P < 0.01 or < 0.05], and the positive granule of Syt Ⅰ was significantly lower in PCL and SR of CA1 and CA3, GL of DG. The average optical value responsible for Syt Ⅰ immunoreactivity was obviously reduced in SO(0.048±0.007), PCL(0.299±0.035), SR(0.042±0.007), SLM(0.038±0.006) of CA1, PCL(0.085± 0.019), SR(0.040±0.011), SLM (0.038±0.006) of CA3, GL (0.076±0.019) of DG than normal controls (0.068± 0.014, 0.376±0.053, 0.053±0.008,0.056±0.009,0.118±0.026,0.052±0.010,0.053±0.009,0.099±0.015; P< 0.01 or < 0.05). Serum T3 and T4 levels [(1.43±0.30), (157.18±19.95)nmol/L]of hyperthyroid rats were significantly higher than those of control group(P < 0.01). The value was reduced in PCL(0.322±0.050), SR(0.039±0.006), SLM (0.042±0.006) of CA1, PCL(0.098±0.034), SR(0.046±0.013), SLM(0.046±0.010) of CA3 and GL(0.085± 0.024), ML (0.042±0.009) of DG (P < 0.05 or < 0.01). Conclusion Adult-onset of hypothyroidism and hyperthyroidism can reversibly decrease the expression of Syt Ⅰ in CA1, CA3 and DG regions of hippocampus.     

Effect of thyroid hormone level on the expression of synaptotagmin Ⅰ in adult rat hippocampus

Objective To observe the effect of different thyroid hormone level on the expression of synaptotagmin Ⅰ(Syt Ⅰ) in adult rat hippocampus. Methods All 28 adult male SD rats were assigned randomly into hypothyroid, hyperthyroid and control group, hypothyroid group was established by daily intraperitoneal injections with propylthiou raci(PTU, 10.0 mg/kg body weight) for 6 weeks and hyperthyroid group with L-Thyroxine (L-T4, 0.5 mg/kg body weight) for 3 weeks. Radioimmunity method was used to assay the levels of serum T3 and T4, immunohistochemical S-P technology to assay the levels of Syt Ⅰ protein in hippoeampus CA1, CA3 and dentate gyrus (DG). The layers analyzed in the different subfields include the polymorphic cell layer(the stratum oriens, SO), pyramidal cell layer(PCL), stratum radiatum (SR), lacunosum-molecular layer (SLM) in CA1 and CA3, granular cell layer(GL) and molecular layer(ML) in DG. Results The levels of serum T3 and T4[(0.34±0.12), (41.03± 11.37)nmol/L]in the hypothyroid rats were significantly lower than those in the control group[(0.65±0.15), (55.20±10.68)nmol/L, P < 0.01 or < 0.05], and the positive granule of Syt Ⅰ was significantly lower in PCL and SR of CA1 and CA3, GL of DG. The average optical value responsible for Syt Ⅰ immunoreactivity was obviously reduced in SO(0.048±0.007), PCL(0.299±0.035), SR(0.042±0.007), SLM(0.038±0.006) of CA1, PCL(0.085± 0.019), SR(0.040±0.011), SLM (0.038±0.006) of CA3, GL (0.076±0.019) of DG than normal controls (0.068± 0.014, 0.376±0.053, 0.053±0.008,0.056±0.009,0.118±0.026,0.052±0.010,0.053±0.009,0.099±0.015; P< 0.01 or < 0.05). Serum T3 and T4 levels [(1.43±0.30), (157.18±19.95)nmol/L]of hyperthyroid rats were significantly higher than those of control group(P < 0.01). The value was reduced in PCL(0.322±0.050), SR(0.039±0.006), SLM (0.042±0.006) of CA1, PCL(0.098±0.034), SR(0.046±0.013), SLM(0.046±0.010) of CA3 and GL(0.085± 0.024), ML (0.042±0.009) of DG (P < 0.05 or < 0.01). Conclusion Adult-onset of hypothyroidism and hyperthyroidism can reversibly decrease the expression of Syt Ⅰ in CA1, CA3 and DG regions of hippocampus.     

Effect of thyroid hormone level on the expression of synaptotagmin Ⅰ in adult rat hippocampus

Objective To observe the effect of different thyroid hormone level on the expression of synaptotagmin Ⅰ(Syt Ⅰ) in adult rat hippocampus. Methods All 28 adult male SD rats were assigned randomly into hypothyroid, hyperthyroid and control group, hypothyroid group was established by daily intraperitoneal injections with propylthiou raci(PTU, 10.0 mg/kg body weight) for 6 weeks and hyperthyroid group with L-Thyroxine (L-T4, 0.5 mg/kg body weight) for 3 weeks. Radioimmunity method was used to assay the levels of serum T3 and T4, immunohistochemical S-P technology to assay the levels of Syt Ⅰ protein in hippoeampus CA1, CA3 and dentate gyrus (DG). The layers analyzed in the different subfields include the polymorphic cell layer(the stratum oriens, SO), pyramidal cell layer(PCL), stratum radiatum (SR), lacunosum-molecular layer (SLM) in CA1 and CA3, granular cell layer(GL) and molecular layer(ML) in DG. Results The levels of serum T3 and T4[(0.34±0.12), (41.03± 11.37)nmol/L]in the hypothyroid rats were significantly lower than those in the control group[(0.65±0.15), (55.20±10.68)nmol/L, P < 0.01 or < 0.05], and the positive granule of Syt Ⅰ was significantly lower in PCL and SR of CA1 and CA3, GL of DG. The average optical value responsible for Syt Ⅰ immunoreactivity was obviously reduced in SO(0.048±0.007), PCL(0.299±0.035), SR(0.042±0.007), SLM(0.038±0.006) of CA1, PCL(0.085± 0.019), SR(0.040±0.011), SLM (0.038±0.006) of CA3, GL (0.076±0.019) of DG than normal controls (0.068± 0.014, 0.376±0.053, 0.053±0.008,0.056±0.009,0.118±0.026,0.052±0.010,0.053±0.009,0.099±0.015; P< 0.01 or < 0.05). Serum T3 and T4 levels [(1.43±0.30), (157.18±19.95)nmol/L]of hyperthyroid rats were significantly higher than those of control group(P < 0.01). The value was reduced in PCL(0.322±0.050), SR(0.039±0.006), SLM (0.042±0.006) of CA1, PCL(0.098±0.034), SR(0.046±0.013), SLM(0.046±0.010) of CA3 and GL(0.085± 0.024), ML (0.042±0.009) of DG (P < 0.05 or < 0.01). Conclusion Adult-onset of hypothyroidism and hyperthyroidism can reversibly decrease the expression of Syt Ⅰ in CA1, CA3 and DG regions of hippocampus.     

Effect of thyroid hormone level on the expression of synaptotagmin Ⅰ in adult rat hippocampus

Objective To observe the effect of different thyroid hormone level on the expression of synaptotagmin Ⅰ(Syt Ⅰ) in adult rat hippocampus. Methods All 28 adult male SD rats were assigned randomly into hypothyroid, hyperthyroid and control group, hypothyroid group was established by daily intraperitoneal injections with propylthiou raci(PTU, 10.0 mg/kg body weight) for 6 weeks and hyperthyroid group with L-Thyroxine (L-T4, 0.5 mg/kg body weight) for 3 weeks. Radioimmunity method was used to assay the levels of serum T3 and T4, immunohistochemical S-P technology to assay the levels of Syt Ⅰ protein in hippoeampus CA1, CA3 and dentate gyrus (DG). The layers analyzed in the different subfields include the polymorphic cell layer(the stratum oriens, SO), pyramidal cell layer(PCL), stratum radiatum (SR), lacunosum-molecular layer (SLM) in CA1 and CA3, granular cell layer(GL) and molecular layer(ML) in DG. Results The levels of serum T3 and T4[(0.34±0.12), (41.03± 11.37)nmol/L]in the hypothyroid rats were significantly lower than those in the control group[(0.65±0.15), (55.20±10.68)nmol/L, P < 0.01 or < 0.05], and the positive granule of Syt Ⅰ was significantly lower in PCL and SR of CA1 and CA3, GL of DG. The average optical value responsible for Syt Ⅰ immunoreactivity was obviously reduced in SO(0.048±0.007), PCL(0.299±0.035), SR(0.042±0.007), SLM(0.038±0.006) of CA1, PCL(0.085± 0.019), SR(0.040±0.011), SLM (0.038±0.006) of CA3, GL (0.076±0.019) of DG than normal controls (0.068± 0.014, 0.376±0.053, 0.053±0.008,0.056±0.009,0.118±0.026,0.052±0.010,0.053±0.009,0.099±0.015; P< 0.01 or < 0.05). Serum T3 and T4 levels [(1.43±0.30), (157.18±19.95)nmol/L]of hyperthyroid rats were significantly higher than those of control group(P < 0.01). The value was reduced in PCL(0.322±0.050), SR(0.039±0.006), SLM (0.042±0.006) of CA1, PCL(0.098±0.034), SR(0.046±0.013), SLM(0.046±0.010) of CA3 and GL(0.085± 0.024), ML (0.042±0.009) of DG (P < 0.05 or < 0.01). Conclusion Adult-onset of hypothyroidism and hyperthyroidism can reversibly decrease the expression of Syt Ⅰ in CA1, CA3 and DG regions of hippocampus.     

Effect of thyroid hormone level on the expression of synaptotagmin Ⅰ in adult rat hippocampus

Objective To observe the effect of different thyroid hormone level on the expression of synaptotagmin Ⅰ(Syt Ⅰ) in adult rat hippocampus. Methods All 28 adult male SD rats were assigned randomly into hypothyroid, hyperthyroid and control group, hypothyroid group was established by daily intraperitoneal injections with propylthiou raci(PTU, 10.0 mg/kg body weight) for 6 weeks and hyperthyroid group with L-Thyroxine (L-T4, 0.5 mg/kg body weight) for 3 weeks. Radioimmunity method was used to assay the levels of serum T3 and T4, immunohistochemical S-P technology to assay the levels of Syt Ⅰ protein in hippoeampus CA1, CA3 and dentate gyrus (DG). The layers analyzed in the different subfields include the polymorphic cell layer(the stratum oriens, SO), pyramidal cell layer(PCL), stratum radiatum (SR), lacunosum-molecular layer (SLM) in CA1 and CA3, granular cell layer(GL) and molecular layer(ML) in DG. Results The levels of serum T3 and T4[(0.34±0.12), (41.03± 11.37)nmol/L]in the hypothyroid rats were significantly lower than those in the control group[(0.65±0.15), (55.20±10.68)nmol/L, P < 0.01 or < 0.05], and the positive granule of Syt Ⅰ was significantly lower in PCL and SR of CA1 and CA3, GL of DG. The average optical value responsible for Syt Ⅰ immunoreactivity was obviously reduced in SO(0.048±0.007), PCL(0.299±0.035), SR(0.042±0.007), SLM(0.038±0.006) of CA1, PCL(0.085± 0.019), SR(0.040±0.011), SLM (0.038±0.006) of CA3, GL (0.076±0.019) of DG than normal controls (0.068± 0.014, 0.376±0.053, 0.053±0.008,0.056±0.009,0.118±0.026,0.052±0.010,0.053±0.009,0.099±0.015; P< 0.01 or < 0.05). Serum T3 and T4 levels [(1.43±0.30), (157.18±19.95)nmol/L]of hyperthyroid rats were significantly higher than those of control group(P < 0.01). The value was reduced in PCL(0.322±0.050), SR(0.039±0.006), SLM (0.042±0.006) of CA1, PCL(0.098±0.034), SR(0.046±0.013), SLM(0.046±0.010) of CA3 and GL(0.085± 0.024), ML (0.042±0.009) of DG (P < 0.05 or < 0.01). Conclusion Adult-onset of hypothyroidism and hyperthyroidism can reversibly decrease the expression of Syt Ⅰ in CA1, CA3 and DG regions of hippocampus.     

Effect of thyroid hormone level on the expression of synaptotagmin Ⅰ in adult rat hippocampus

Objective To observe the effect of different thyroid hormone level on the expression of synaptotagmin Ⅰ(Syt Ⅰ) in adult rat hippocampus. Methods All 28 adult male SD rats were assigned randomly into hypothyroid, hyperthyroid and control group, hypothyroid group was established by daily intraperitoneal injections with propylthiou raci(PTU, 10.0 mg/kg body weight) for 6 weeks and hyperthyroid group with L-Thyroxine (L-T4, 0.5 mg/kg body weight) for 3 weeks. Radioimmunity method was used to assay the levels of serum T3 and T4, immunohistochemical S-P technology to assay the levels of Syt Ⅰ protein in hippoeampus CA1, CA3 and dentate gyrus (DG). The layers analyzed in the different subfields include the polymorphic cell layer(the stratum oriens, SO), pyramidal cell layer(PCL), stratum radiatum (SR), lacunosum-molecular layer (SLM) in CA1 and CA3, granular cell layer(GL) and molecular layer(ML) in DG. Results The levels of serum T3 and T4[(0.34±0.12), (41.03± 11.37)nmol/L]in the hypothyroid rats were significantly lower than those in the control group[(0.65±0.15), (55.20±10.68)nmol/L, P < 0.01 or < 0.05], and the positive granule of Syt Ⅰ was significantly lower in PCL and SR of CA1 and CA3, GL of DG. The average optical value responsible for Syt Ⅰ immunoreactivity was obviously reduced in SO(0.048±0.007), PCL(0.299±0.035), SR(0.042±0.007), SLM(0.038±0.006) of CA1, PCL(0.085± 0.019), SR(0.040±0.011), SLM (0.038±0.006) of CA3, GL (0.076±0.019) of DG than normal controls (0.068± 0.014, 0.376±0.053, 0.053±0.008,0.056±0.009,0.118±0.026,0.052±0.010,0.053±0.009,0.099±0.015; P< 0.01 or < 0.05). Serum T3 and T4 levels [(1.43±0.30), (157.18±19.95)nmol/L]of hyperthyroid rats were significantly higher than those of control group(P < 0.01). The value was reduced in PCL(0.322±0.050), SR(0.039±0.006), SLM (0.042±0.006) of CA1, PCL(0.098±0.034), SR(0.046±0.013), SLM(0.046±0.010) of CA3 and GL(0.085± 0.024), ML (0.042±0.009) of DG (P < 0.05 or < 0.01). Conclusion Adult-onset of hypothyroidism and hyperthyroidism can reversibly decrease the expression of Syt Ⅰ in CA1, CA3 and DG regions of hippocampus.     

Effect of thyroid hormone level on the expression of synaptotagmin Ⅰ in adult rat hippocampus

Objective To observe the effect of different thyroid hormone level on the expression of synaptotagmin Ⅰ(Syt Ⅰ) in adult rat hippocampus. Methods All 28 adult male SD rats were assigned randomly into hypothyroid, hyperthyroid and control group, hypothyroid group was established by daily intraperitoneal injections with propylthiou raci(PTU, 10.0 mg/kg body weight) for 6 weeks and hyperthyroid group with L-Thyroxine (L-T4, 0.5 mg/kg body weight) for 3 weeks. Radioimmunity method was used to assay the levels of serum T3 and T4, immunohistochemical S-P technology to assay the levels of Syt Ⅰ protein in hippoeampus CA1, CA3 and dentate gyrus (DG). The layers analyzed in the different subfields include the polymorphic cell layer(the stratum oriens, SO), pyramidal cell layer(PCL), stratum radiatum (SR), lacunosum-molecular layer (SLM) in CA1 and CA3, granular cell layer(GL) and molecular layer(ML) in DG. Results The levels of serum T3 and T4[(0.34±0.12), (41.03± 11.37)nmol/L]in the hypothyroid rats were significantly lower than those in the control group[(0.65±0.15), (55.20±10.68)nmol/L, P < 0.01 or < 0.05], and the positive granule of Syt Ⅰ was significantly lower in PCL and SR of CA1 and CA3, GL of DG. The average optical value responsible for Syt Ⅰ immunoreactivity was obviously reduced in SO(0.048±0.007), PCL(0.299±0.035), SR(0.042±0.007), SLM(0.038±0.006) of CA1, PCL(0.085± 0.019), SR(0.040±0.011), SLM (0.038±0.006) of CA3, GL (0.076±0.019) of DG than normal controls (0.068± 0.014, 0.376±0.053, 0.053±0.008,0.056±0.009,0.118±0.026,0.052±0.010,0.053±0.009,0.099±0.015; P< 0.01 or < 0.05). Serum T3 and T4 levels [(1.43±0.30), (157.18±19.95)nmol/L]of hyperthyroid rats were significantly higher than those of control group(P < 0.01). The value was reduced in PCL(0.322±0.050), SR(0.039±0.006), SLM (0.042±0.006) of CA1, PCL(0.098±0.034), SR(0.046±0.013), SLM(0.046±0.010) of CA3 and GL(0.085± 0.024), ML (0.042±0.009) of DG (P < 0.05 or < 0.01). Conclusion Adult-onset of hypothyroidism and hyperthyroidism can reversibly decrease the expression of Syt Ⅰ in CA1, CA3 and DG regions of hippocampus.     

成年期甲状腺功能减退症大鼠额叶突触结合蛋白I表达及T4替代治疗作用

目的 观察成年期甲状腺功能减退症(甲减)大鼠额叶突触结合蛋白I(synaptotagmin I,sytI)表达改变及不同剂量甲状腺素替代治疗的作用.方法 将44只大鼠按体质量随机分为甲减组、常规治疗组、大剂量治疗组、对照组,用丙基硫氧嘧啶(PTU)腹腔注射建立成年期大鼠甲减及治疗模型;放射免疫法测定4组大鼠血清甲状腺激素水平,免疫组织化学S-P法分析sytI蛋白在4组大鼠额叶分子层、外颗粒层、外锥体细胞层、内颗粒层、内锥体细胞层中的表达.结果 甲减组大鼠血清T3、T4[(0.34±0.04)、(43.01±2.95)nmol/L]显著低于对照组[(0.65±0.15)、(55.20±3.56)nmol/L,F值分别为6.026、4.503,P<0.05或<0.01],甲减组鼠syt I免疫反应产物在额叶分子层(0.018±0.010)、外颗粒层(0.020±0.007)、外锥体细胞层(0.013±0.008)、内颗粒层(0.011±0.005)、内锥体细胞层(0.024±0.013)均较对照组(0.028±0.010、0.031±0.010、0.028±0.010、0.022±0.008、0.038±0.013)明显减少(F值分别为5.697、8.965、14.668、13.597、6.807,P<0.05或<0.01).常规治疗组大鼠血清T3、T4[(0.63±0.05)、(55.04±3.77)nmoL/L]与对照组比较,差异无统计学意义(F值分别为3.162、0.367,P均>0.05),额叶分子层、外颗粒层、外锥体细胞层、内颗粒层、内锥体细胞层syt I蛋白表达(0.027±0.013、0.025±0.009、0.022±0.008、0.020±0.010、0.033±0.010)与对照组比较差异均无统计学意义(F值分别为0.094、2.208、2.467、0.350、0.693,P均>0.05);大剂量治疗组大鼠血清T3、T4[(1.11±0.10)、(96.68±6.42)nmol/L]显著高于对照组(F值分别为6.291、12.031,P均<0.01),额叶各层syt I蛋白表达(0.028±0.008、0.031±0.011、0.026±0.012、0.023±0.011、0.038±0.010)与对照组比较的差异均无统计学意义(F值分别为0.001、0.019、0.111、0.061、0.001,P均>0.05).结论 成年期甲减大鼠额叶内syt I蛋白表达减少,常规剂量甲状腺素替代治疗就能使其恢复至正常水平.     

神经生长相关蛋白在甲状腺功能减退 新生鼠大脑的表达

目的　研究甲状腺激素缺乏对新生鼠大脑神经生长相关蛋白表达的影响。方法　选用他巴唑复制的甲状腺功能减退（甲减）大鼠动物模型，用免疫细胞化学方法结合图像分析对正常及甲减新生鼠大脑内神经生长相关蛋白的动态变化进行研究。结果　甲减新生鼠顶叶皮质及海马结构内生长相关蛋白的分布趋势与正常对照组相似。顶叶皮质表现为分子层染色最深，海马结构表现为腔隙层、放射层及始层梯度染色，神经元胞体一般不染色。图像分析显示生后15d甲减鼠大脑生长相关蛋白灰度值较正常对照组明显升高（P<0.01）；生后30d，其灰度值虽低于正常对照组，但经统计学分析差异无显著意义（P>0.05）。结论　甲状腺激素直接或间接影响神经生长相关蛋白的表达。甲状腺激素可能通过调控神经生长相关蛋白，进而影响G0蛋白信号转导系统及第二信号系统，调控鼠脑的发育。     

Shh信号通路相关基因表达调控甲状腺功能减退的机制

目的探讨甲状腺功能减退(甲减)大鼠海马组织中Shh信号通路信号肽Shh、膜受体Patched-1和核转录因子Gli-1的表达及甲减对脑发育及功能调控影响的分子机制。方法 12只SPF级健康Wistar大鼠按照随机字数表法分为对照组和甲减组,每组6只,甲减组经腹腔注射丙基硫氧嘧啶建模,对照组经腹腔注射生理盐水,测定两组三碘甲状腺原氨酸(T3)、T4及促甲状腺激素(TSH)水平,对比两组Shh、Patched-1和Gli-1蛋白水平及mRNA表达。结果与对照组比较,甲减组大鼠血清T3、T4水平明显降低,TSH水平明显升高(P<0.05)。甲减组Shh,Patched-1及Gli-1蛋白及mRNA表达相比对照组均明显降低(P<0.05)。结论甲减脑组织Shh、Patched-1和Gli-1蛋白水平及mRNA表达明显降低,导致甲状腺激素生物学效应降低,为甲状腺功能减退的临床治疗打下坚实基础。     

甲状腺功能减退大鼠脑海马组织T3核受体基因表达

目的了解甲状腺功能减退(简称甲减)大鼠海马组织T3核受体(T3NR)α、β亚型mRNA的特异性变化,探讨甲状腺激素对脑发育及功能调控的分子机制。方法采用丙基硫氧嘧啶(PTU)腹腔注射诱发甲减动物模型,运用RT-PCR检测技术测定实验性甲减大鼠脑海马组织T3NRα1mRNA、T3NRβ1mRNA的表达水平。结果甲减大鼠海马组织T3NRα1mRNA、T3NRβ1mRNA的表达水平明显下调,与正常对照组比较差异有统计学意义(P<0.01)。结论甲减时脑组织T3NRα、β亚型mRNA的表达水平下调,T3NR的合成减少,导致甲状腺激素的生物效应的降低,可能是甲减性脑损害发生的重要病理机制之一。     

高碘对新生鼠大脑神经生长相关蛋白表达的影响

目的 研究新生鼠大脑内神经生长相关蛋白的分布及高碘对黄表达的影响。和碘化油诱导建立高碘大鼠动物模型；采用甲状腺激素定量测定、免疫细胞化学方法结合图像分析研究了高碘及正常新生鼠大脑内神经生长相关蛋白表达的差异。结果 ①高碘可引起血清甲状腺激素（Ｔ３↓，Ｔ３／Ｔ４↑）；②高碘及正常新生鼠顶叶皮质及海巴结构内生长相关蛋白的分布趋势相似，表现为顶叶皮质分子层染色深，海马结构表现为腔隙层、放射层及始层梯度染     

大鼠脑发育临界期内甲亢和甲减对中枢胆碱能神经元发育的影响

对20日龄的甲亢及甲减大鼠的海马、大脑皮层、前脑基底和小脑中乙酰胆碱转移酶(CHAT)、乙酰胆碱酯梅(ACHE)各亚类的活性进行了测定.结果显示,胆碱能神经元是甲状腺激素的靶神经元.在脑发育临界期,甲亢和甲减均会造成各脑区胆碱能神经元突触发育障碍.甲状腺激素缺乏可使胆碱能神经元的发育和成熟明显落后,而甲状腺激素水平增高对胆碱能神经元成熟的影响在各脑区有差异:在大脑皮层增高,海马降低,前脑基底和小脑无明显变化.由于CHAT和ACHE对甲状腺激素水工的改变在不同脑区反应的差异可能造成乙酰胆碱的代谢紊乱.     

大鼠脑缺血后海马CA1区脑红蛋白表达的变化及肢体缺血预处理对其影响

目的 观察青年和老年大鼠脑缺血后海马CA1区脑红蛋白(Ngb)表达的变化及肢体缺血预处理(LIP)对其影响. 方法 将凝闭双侧椎动脉的青年和老年大鼠均随机分为脑缺血组和脑缺血+LIP组.采用反转录聚合酶链反应(RT-PCR)和Western blot法检测海马CA1区NgbmRNA和蛋白表达,硫堇染色观察海马CA1区锥体神经元迟发性死亡(DND)情况. 结果 青年脑缺血组、青年脑缺血+LIP组、老年脑缺血组、老年脑缺血+LIP组的Ngb mRNA和蛋白表达分别为0.16±0.02和0.32±0.07、0.52±0.04和0.91±0.06、0.09±0.01和0.22±0.08、0.21±0.01和0.66±0.06.表明老年大鼠脑缺血后海马CA1区Ngb mRNA和蛋白表达较青年脑缺血大鼠降低(P<0.05),LIP可上调青年和老年大鼠脑缺血后海马CA1区Ngb mRNA和蛋白表达(P<0.05),但对老年大鼠的上调作用低于青年大鼠(P<0.05).硫堇染色显示,海马CA1区神经元密度青年脑缺血组,青年脑缺血+LIP组、老年脑缺血组和老年脑缺血+LIP组分别为(38.8±10.9)、(171.5±16.9)、(21.2±12.2)个/mm和(102.7±15.4)个/mm.表明老年大鼠LIP预防脑缺血引起的海马CA1区锥体神经元DND的作用小于青年大鼠. 结论 老年大鼠脑缺血后Ngb的表达及LIP对其上调作用较青年大鼠明显减弱,这可能是老年大鼠脑缺血后损伤较重和LIP对老年大鼠脑缺血保护作用较弱的原因之一.     

甲状腺功能减退对雄性大鼠精子活动度的影响

目的 探讨甲状腺功能减退(甲减)对雄性大鼠精子活动度的影响.方法 健康雄性Wistar大鼠20只,体质量200～240 g,按体质量随机分为2组:生理盐水(对照)组和甲减组(按1 ml/100 g体质量灌服0.1％丙硫氧嘧啶),每组10只,共60d,每3天称体质量.灌胃结束次日处死大鼠,取全血,分离血清.放射免疫法检测血清中甲状腺激素水平:总三碘甲状腺素原氨酸(T3)、总甲状腺素(T4)、促甲状腺激素(TSH).取附睾游离精子,WLJY-9000型伟力彩色精子质量检测系统测定精子运动参数:平均路径速度、直线速度、前向性、侧摆幅度、精子密度、曲线速度、直线性、摆动性、平均移动角度、鞭打频率.结果 灌胃第30、60天甲减组大鼠体质量[(239.00±15.02)、(232.67±17.86)g]均低于对照组[(298.20±12.15)、(344.00±13.73)g,t值分别为7.704、11.380,P均＜0.05].甲状腺激素水平:甲减组大鼠T3[(373.3±101.3)ng/L]、T4[(4.00±0.89)×103 ng/L]水平低于对照组[(1000.0±273.5)ng/L、(44.33±7.84)×103 ng/L,t值分别为5.262、2.520,P均＜0.05],TSH[(5.77±0.89)×103 U/L]水平高于对照组[(1.87±0.70)×103 U/L,t=8.413,P＜0.05].精子参数:甲减组平均路径速度[(27.45±1.59)μm/s]、直线速度[(21.08±1.10)μm/s]、前向性[(70.53±3.48)％]、侧摆幅度[(1.96±0.26)μm]高于对照组[(24.38±2.59)μm/s、(17.99±2.06) μm/s、(65.93±2.71)％、(1.53±0.27)μm,t值分别为2.687、2.404、2.420、3.175,P均＜0.05].甲减组精子密度[(5.07±0.74)109/L]低于对照组[(8.76±1.01) 109/L,t=6.463,P＜ 0.05].甲减组曲线速度[(52.83±5.56)μm/s]、直线性[(38.58±3.41)％]、摆动性[(52.64±3.24)％]、平均移动角度[(64.21±6.71)度/s]、鞭打频率[(8.93±0.62)Hz]与对照组[(49.92±6.43)μm/s、(36.52±2.73)％、(52.49±3.49)％、(62.77±7.34)度/s、(9.32±0.61)Hz]比较差异无统计学意义(t值分别为0.805、1.089、0.037、0.341、1.033,P均＞0.05).结论 甲状腺功能减退可影响雄性大鼠精子活动度,降低精子密度,损害大鼠生殖系统.     

高碘对大鼠甲状腺过氧化物酶和钠碘转运体基因mRNA表达的影响

目的 观察长期碘过量对大鼠甲状腺过氧化物酶(TPO)和钠碘转运体(NIS)mRNA表达的影响.方法 将SD大鼠按体质量随机分为对照(CI)组、高碘Ⅰ(HI Ⅰ)组、高碘Ⅱ(HIⅡ)组,分别饮用含碘5、5000、10000μg/L的自来水.6个月时取大鼠甲状腺,在光、电镜下观察甲状腺形态结构的变化;采用放射免疫法测定血清甲状腺激素水平;RT-PCR法检测甲状腺TPO、NIS mRNA的表达.结果 高碘组与CI组相比.部分甲状腺滤泡明显增大,滤泡腔内充满浓染胶质;血清TT4 、TT3水平,HI Ⅰ组[(73.82±16.48)、(1.34±0.31)nmol/L]和HIⅡ组[(70.65±11.43)、(1.15±0.39)nmol/L]与对照组[(75.68±13.99)、(1.45±0.49)nmol/L]相比呈逐渐下降趋势,但组间差异无统计学意义(F值分别为0.371、1.163,P＞0.05);TPO、NIS mRNA表达水平,组间比较差异有统计学意义(F值分别为30.863、62.675,P＜0.05).HI Ⅰ组(1.28±0.10、0.56±0.17)和HIⅡ组(1.14±0.04、0.39±0.06)均比对照组(1.39±0.08、0.71±0.13)明显降低(P＜0.05).结论 长期碘过量可造成甲状腺组织形态学改变,并且抑制甲状腺TPO、NIS mRNA表达.